Gefitero Tablet
Marketer
Hetero Drugs Ltd
Salt Composition
Gefitinib (250mg)
Overview Gefitero Tablet
Gefitinib tablets treat advanced non-small cell lung cancer. This medication is prescribed for patients with metastatic disease, abnormal epidermal growth factor receptor (EGFR) genes, and no prior cancer therapy. Dosage and treatment duration are determined by your physician. Consistent adherence to the prescribed regimen is crucial. Regular liver function monitoring may be recommended. Common adverse reactions encompass diarrhea, xerosis (dry skin), anorexia, and nausea. Adequate hydration can mitigate some side effects. Report any persistent or worsening side effects to your doctor immediately. Seek immediate medical attention if you experience oral ulceration, visual disturbances, or respiratory distress. Women undergoing treatment should utilize reliable contraception and avoid pregnancy throughout treatment and for one month post-treatment. Always disclose all other medications you are currently using to your doctor.
Uses of Gefitero Tablet
Lung cancer (excluding small cell types)
Major Benefits of Gefitero Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Gefitero Tablets. Swallow the tablet whole; avoid chewing, crushing, or breaking it. Gefitero Tablets can be ingested with or without food, however, consistent timing is recommended.
Common Side effects of Gefitero Tablet:
- Diarrhea
- Dry skin
- Loss of appetite
- Nausea
- Rash
- Vomiting
- Weakness
- Weight loss
- Eating disorder
- Allergic reaction
How to use Gefitero Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Gefitero Tablet. Swallow the tablet whole; do not crush, chew, or break it. Gefitero Tablet can be taken with or without food, but consistency in timing is recommended.
How Gefitero Tablet works:
Gefitero tablets are an anti-neoplastic agent. Their mechanism involves inhibiting the activity of a mutated protein responsible for stimulating cancerous proliferation, thus hindering or retarding tumor growth.
SAFETY ADVICE
AlcoholUNSAFE
Combining Gefitero Tablet and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Using Gefitero tablets during pregnancy is contraindicated due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Gefitero Tablets while breastfeeding is likely inadvisable. Preliminary human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by the use of Gefitero Tablets, due to potential side effects.
KidneyCAUTION
Patients with advanced kidney impairment should exercise caution when using Gefitero Tablets. Dosage modifications for Gefitero Tablets may be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Use of Gefitero tablets in patients with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Gefitero Tablet :
Omit any missed Gefitero Tablet dose; resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Gefitero Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline amines |
| Developing Habits | No. |
| Treatment Category | Cancer Drugs |
3,018 People bought this recently